These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12829227)

  • 21. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.
    Onozawa M; Fukuhara T; Takahata M; Yamamoto Y; Miyake T; Maekawa I
    Ann Hematol; 2003 Sep; 82(9):593-5. PubMed ID: 12898186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: a registry-based study.
    Durairaj S; Keenan N; Hyslop A; Groves MJ; Bowen DT; Tauro S
    Br J Haematol; 2013 Apr; 161(2):280-2. PubMed ID: 23294041
    [No Abstract]   [Full Text] [Related]  

  • 23. Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate.
    Mesa RA; Steensma DP; Hoyer J; Ketterling RP
    Br J Haematol; 2003 Oct; 123(2):366-7. PubMed ID: 14531922
    [No Abstract]   [Full Text] [Related]  

  • 24. The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia.
    Wakim JJ; Tirado CA; Dowell J; Chen W
    Cancer Genet; 2012 Mar; 205(3):124-7. PubMed ID: 22469511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
    Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
    Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman MA
    Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea.
    Flamm MJ; Murty VV; Rao PH; Nichols GL
    Leuk Res; 2002 Apr; 26(4):417-20. PubMed ID: 11839390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].
    Zhu Y; Pan LQ; Qian SX; Song P; Yu H; Zhang SJ; Ge Z; Hong M; Tian T; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):581-6. PubMed ID: 23815902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ponatinib in Philadelphia chromosome-positive leukemias.
    Quintas-Cardama A
    N Engl J Med; 2014 Feb; 370(6):577. PubMed ID: 24499222
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization.
    Brynes RK; McCourty A; Ho JP; Traweek ST; Snyder DS; Slovak ML
    Mod Pathol; 1994 Jun; 7(5):565-9. PubMed ID: 7937723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Society of Hematology--50th Annual Meeting and Exposition--Part 1.
    Scattereggia J; Millar E
    IDrugs; 2009 Feb; 12(2):63-5. PubMed ID: 19216123
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukemias and plasma cell myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic myelomonocytic leukemia with overlap dysplastic/proliferative presentation.
    Gologan R; Stoia R; Radulescu I; Georgescu D; Ostroveanu D
    Leuk Res; 2007 Jun; 31(6):878-9. PubMed ID: 16956659
    [No Abstract]   [Full Text] [Related]  

  • 35. Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?
    Kelani R; Monem F
    Int J Lab Hematol; 2015 Oct; 37(5):723-8. PubMed ID: 26059167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Loss of Philadelphia chromosome after graft failure following cord blood transplantation for Philadelphia chromosome-positive acute myeloid leukemia].
    Hamada Y; Nakamura K; Tajika K; Dan K
    Rinsho Ketsueki; 2011 Feb; 52(2):58-62. PubMed ID: 21403424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.
    Silver RT; Bennett JM; Goldman JM; Spivak JL; Tefferi A
    Leuk Res; 2007 Jan; 31(1):11-7. PubMed ID: 16620972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib.
    Popovici C; Cailleres S; David M; Lafage-Pochitaloff M; Sainty D; Mozziconacci MJ
    Leuk Lymphoma; 2005 Sep; 46(9):1375-7. PubMed ID: 16109618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status and future perspective of new drugs for hematological malignancies in Japan].
    Ogura M
    Rinsho Ketsueki; 2007 Oct; 48(10):1442-52. PubMed ID: 17933133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.